肝癌患者就诊时多数为进展期肿瘤或合并肝硬化,仅10%~37%能够接受肝切除术。术后2年内30%~50%的肿瘤复发,5年复发率可高达80%,复发性肝癌能获得再切除者仅占10%~20%。由于外科治疗的应用受到严重限制,事实上绝大多数的患者需要接受区域或局部治疗,其中作为局部治疗的各种消融疗 The majority of patients with hepatocellular carcinoma at the time of treatment for advanced cancer or cirrhosis, only 10% to 37% to accept the liver resection. Within 2 years after operation, 30% to 50% of tumor recurrences can reach up to 80% in 5 years and only 10% to 20% in patients with recurrent HCC. Due to serious limitations in the application of surgical treatment, in fact, the vast majority of patients need to receive regional or local treatment, including local treatment of various ablation